| |
|
|
|
NovaBay Pharmaceuticals Inc.  
|
|
1.46 -0.09 (-0.06%) |
10-22 15:59 |
|
Open: |
1.56 |
Pre close: |
1.55 |
Target:
|
2.31
|
|
High: |
1.59 |
Low: |
1.45 |
Resistance:
|
1.98
2.40
|
|
Volume: |
7,735 |
Market Cap: |
25M |
Support:
|
1.30
1.08
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.56
 |
MACD |
MACD(12,26):
|
-0.05 |
|
MA(20): |
1.66 |
Signal(12,26,9): |
-0.05 |
|
MA(100): |
2.06 |
Stochastic Oscillator |
%K(14,3):
|
25.93 |
|
MA(250): |
2.95 |
%D(3): |
26.44 |
|
Average Volume(K) |
3-Month: |
2059
|
52-Week |
High:
|
4.80 |
|
10-Days: |
1173 |
Low: |
1.25 |
|
RSI |
RSI(14):
|
44.05 |
Change(%): |
-64.7 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.430 |
Return on Equity (ttm) |
-101.4 |
Shares Out. (M) |
17.09 |
|
EPS Est. Current Year |
-0.470 |
Return on Assets (ttm) |
-45.4 |
Shares Float (M) |
15.31 |
|
EPS Est. Next Year |
-0.090 |
PEG Ratio |
0.00 |
% Held by Insiders |
10.40 |
|
EPS Est. Next Quarter |
-0.030 |
Qtrly Rev. Growth |
-32.2 |
% Held by Institutions |
10.80 |
|
Forward EPS |
-0.170 |
Gross Profit (p.s.) |
0.209 |
Shares Short (K) |
71 |
|
Book Value (p.s.) |
3.570 |
EBITDA (p.s.) |
-0.126 |
P/E |
-3.53 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.43 |
|
Profit Margin |
-24.58 |
Operating Cash Flow
(M) |
-4.60 |
P/S |
25719604.00 |
|
Operating Margin |
-38.57 |
Levered Free Cash Flow
(M) |
-2.91 |
P/CF |
-5.65 |
|
|
|
|
|
|
